Module 375 Residual: 0.53
Mycobacterium smegmatis (strain ATCC 700084 / mc(2)155)

Residual Motif 1 e-value Motif 2 e-value Conditions Genes version
0.53 0.0056 52 76 17 20160204
Motif 1
e-value: 0.0056
e-value: 52
MSMEG_2066 Uncharacterized protein MSMEG_5407 Integral membrane protein (Putative integral membrane protein)
MSMEG_2067 Methyltransferase type 12 MSMEG_4181 Phosphoribosyl-ATP pyrophosphatase (PRA-PH) (EC 3.6.1.31)
MSMEG_6712 Iron-containing alcohol dehydrogenase (Maleylacetate reductase) (EC 1.3.1.32) (Maleylacetate reductase) MSMEG_2444 Dienelactone hydrolase (EC 3.1.1.45) (Dienelactone hydrolase family protein)
MSMEG_1005 Methyltransferase type 11 MSMEG_6792 Gluconate permease (Inner membrane permease YgbN)
MSMEG_1621 Pyrimidine-specific ribonucleoside hydrolase RihA (EC 3.2.-.-) MSMEG_1789 Uncharacterized protein
MSMEG_6947 Chromosomal replication initiator protein DnaA MSMEG_1788 Uncharacterized protein
MSMEG_2036 Hydrolase, alpha/beta fold family protein (Non-heme haloperoxidase Hpx) MSMEG_6006 Uncharacterized protein
MSMEG_6438 Uncharacterized protein MSMEG_1774 Uncharacterized protein
MSMEG_1791 UsfY protein
KO_stationary.phase_rep2
Biological.replicate.5.of.7..falcarinol.treatment
X4XR.rep1
WT.vs..DamtR.without.N_rep2
Plogcy5plogcy3slide110norm
Biological.replicate.4.of.7..ethambutol.treatment
Bedaquiline.vs..DMSO.30min
Biological.replicate.1.of.6..negative.control
dosR.WT_Replicate3
Tet.CarD.vs.Control..Replicates.1..2..and.3.
dosR.WT_Replicate1
Biological.replicate.2.of.6..kanamycin.treatment
Stationary.cultures.induced.to.express.I.SceI.for.45.minutes..T.45...ATc.
Stationary.cultures.control.without.induction.of.I.SceI.expression..T.0...Atc.
Biological.replicate.3.of.7..panaxydol.treatment
MB100pruR.vs..MB100.rep.2
WT.vs..DamtR.without.N_.dyeswap_rep1
WT.vs..DamtR.without.N_.dyeswap_rep2
MB100pruR.vs..MB100.rep.1
Biological.replicate.1.of.6..isoniazid.treatment
Biological.replicate.7.of.7..ethambutol.treatment
Biological.replicate.1.of.7..ethambutol.treatment
Biological.replicate.6.of.6..kanamycin.treatment
rel.knockout.rep1
Bedaquiline.vs..DMSO..45min
Biological.replicate.5.of.6..isoniazid.treatment
Biological.replicate.6.of.7..panaxydol.treatment
M..smegmatis.Acid.NO.treated
Biological.replicate.3.of.7..ethambutol.treatment
Biological.replicate.4.of.6..kanamycin.treatment
WT_log.phase_rep2
X0.6..vs..50..air.saturation.Replicate.3
M.smegmatis_mc2_155_dMSMEG_0166_study_mutant_rep1
X0.6..vs..50..air.saturation.Replicate.4
M.smegmatis_mc2_155_dMSMEG_0166_study_mutant_rep3
M.smegmatis_mc2_155_dMSMEG_0166_study_mutant_rep2
Biological.replicate.5.of.6..kanamycin.treatment
Biological.replicate.7.of.7..panaxydol.treatment
X3dbfcy3plogcy5slide607norm
dcpA.knockout.rep1
Plogcy5plogcy3slide111norm
X3dbfcy5plogcy3slide601norm
X2.5..vs..50..air.saturation.Replicate.5
stphcy3plogcy5slide581norm
WT_log.phase_rep1
Biological.replicate.4.of.7..panaxydol.treatment
X2.5..vs..50..air.saturation.Replicate.3
WT_stationary.phase_rep2
Log.phase.cultures.induced.to.express.I.SceI.for.45.minutes..T.45...ATc.
Biological.replicate.6.of.6..isoniazid.treatment
X4XR.rep2
Biological.replicate.5.of.7..ethambutol.treatment
Slow.vs..Fast.Replicate.4
Slow.vs..Fast.Replicate.5
Bedaquiline.vs..DMSO.60min
Biological.replicate.4.of.7..falcarinol.treatment
Slow.vs..Fast.Replicate.1
Biological.replicate.6.of.7..ethambutol.treatment
Slow.vs..Fast.Replicate.3
BatchCulture_LBTbroth_ExponentialPhase_Replicate2
BatchCulture_LBTbroth_ExponentialPhase_Replicate1
Wild.type.rep3
X4dbfcy5plogcy3slide901norm
WT.vs..DamtR.N.surplus_.dyeswap_rep1
Log.phase.cultures.without.induction.of.I.SceI.expression..T.0...Atc.
Biological.replicate.1.of.7..falcarinol.treatment
X2XR.rep1
Biological.replicate.1.of.7..panaxydol.treatment
Slow.vs..Fast.Replicate.2
JR121..pJR29.VapC..vs..JR121..pJR230..VapBC..rep2
Plogcy5plogcy3slide113norm
dosR.WT_Replicate2
Biological.replicate.4.of.6..isoniazid.treatment
M.smegmatis_mc2_155_dMSMEG_0166_study_wild.type_rep1
Biological.replicate.1.of.6..kanamycin.treatment
Bedaquiline.vs..DMSO.120min
Log in to post comments